VICTORY CAPITAL MANAGEMENT INC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 160 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$14,000
-12.5%
2,619
+7.2%
0.00%
Q2 2016$16,000
+45.5%
2,443
+2.1%
0.00%
Q1 2016$11,0000.0%2,392
+8.5%
0.00%
Q4 2015$11,000
+57.1%
2,205
+5.9%
0.00%
Q3 2015$7,000
-77.4%
2,083
-32.6%
0.00%
Q2 2015$31,000
-86.3%
3,089
-82.6%
0.00%
-100.0%
Q1 2015$226,000
-96.2%
17,750
-95.8%
0.00%
-95.5%
Q4 2014$5,937,000419,5750.02%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
VHCP Management, LLC 700,273$10,770,0005.76%
HARVEY CAPITAL MANAGEMENT INC 932,400$14,340,0005.13%
Camber Capital Management LP 3,000,000$46,140,0003.02%
Baupost Group 10,539,986$162,105,0002.64%
SECTORAL ASSET MANAGEMENT INC 3,741,656$57,547,0002.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,884,409$59,742,0002.40%
Knoll Capital Management, LLC 200,000$3,076,0001.37%
DAFNA Capital Management LLC 92,400$1,421,0001.35%
NORTHPOINTE CAPITAL LLC 892,011$13,719,0001.32%
Rhenman & Partners Asset Management AB 240,000$3,691,0001.10%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders